山西排便带血怎么回事(山西痔疮的症状及种类) (今日更新中)

SAN FRANCISCO, March 21 (Xinhua) -- Microsoft on Monday sued Barnes & Noble, claiming patent infringement by the largest book retailer in the United States.Microsoft said it filed legal actions on Monday in both the U.S. International Trade Commission and the U.S. District Court of the Western District of Washington against Barnes & Noble, as well as Foxconn and Inventec, two manufacturers of Barnes & Noble's devices.According to Microsoft, the actions focus on the patent infringement by Barnes & Noble's Nook e-reader and tablet, both of which run Google's Android operating system.The patents at issue cover a range of functionality embodied in Android devices that are essential to the user experience, including natural ways of interacting with devices by tabbing through various screens to find the information they need, surfing the Web more quickly and interacting with documents and e-books, Microsoft said in a press release."The Android platform infringes a number of Microsoft's patents, and companies manufacturing and shipping Android devices must respect our intellectual property rights," Horacio Gutierrez, Microsoft's corporate vice president and deputy general counsel, was quoted by the press release as saying.Writing in a separate company blog post, Gutierrez said that the latest actions bring to 25 the total number of Microsoft patents in litigation for infringement by Android smartphones, tablets and other devices.He noted that Microsoft has established a licensing program to address Android's ongoing infringement, and leading Android smartphone manufacturer HTC has taken a license under this program.Amazon.com also signed a patent license with Microsoft last year covering its Kindle e-reader, he added."Unfortunately, after more than a year of discussions, Barnes & Noble, Foxconn and Inventec have so far been unwilling to sign a license, and therefore, we have no other choice but to bring legal action to defend our innovations," Gutierrez said in the blog post.

BEIJING, Feb. 2 (Xinhua) -- Two more planes flew 435 more Chinese back home from Egypt Wednesday afternoon.An airliner with 213 Chinese from Cairo landed at the Beijing Capital International Airport at 2:19 p.m., and another with 222 Chinese including many Hong Kong people from Luxor landed at a Hong Kong airport at 3:25 p.m..These flights were another strive of the Chinese government and airline operators to get stranded Chinese nationals out of Egypt, where anti-government demonstrations have led to chaos in several major cities including Cairo.So far, 1371 stranded Chinese had been taken home by six flights.

LOS ANGELES, May 15 (Xinhua) -- Using a simple, minimally- invasive technique to analyze cells from the interior of the nose, U.S. researchers have detected lung cancer in its earliest stage.For the study, the researchers at the Boston University Medical Center collected nasal epithelial cells from thirty three smokers who were undergoing medically-indicated bronchoscopies for suspicion of lung cancer, according to the American Association for the Advancement of Science (AAAS) on Sunday.Of these patients, 11 were found to have benign disease and 22 had lung cancer. Brushings were taken from the right or left nostril and profiled on microarrays, a process that allows researchers to study gene expression changes.The researchers identified 170 genes that were differentially expressed between patients with and without lung cancer. They also found that genes linked to colon cancer and adenocarcinoma, as well as genes that trigger cell division and blood vessel growth, were expressed more heavily in patients with cancer. Genes involved in tumor suppression were also expressed at lower levels in these patients.Earlier studies have used gene expression differences in the bronchial airways to identify lung cancer in its early stages. The researchers relied on those results to design the current study."In this study we used the same principle as we used in our earlier studies of bronchial tissue, only this time, those methods were used to study nasal cells," said study author Christina Anderlind, MD, Instructor of Medicine. "Our hypothesis was that the upper airway epithelium of smokers with lung cancer displays a cancer-specific gene expression pattern, and that this airway nasal gene expression signature reflects the changes that occur in lung tissue."

HARBIN, March 2 (Xinhua) -- A therapeutic apparatus to treat Parkinson's disease has been developed in northeast China's Heilongjiang Province, according to the provincial science and technology department. It is a worldwide breakthrough in treating the disease with transcranial magnetic stimulation, concluded an expert panel with the Heilongjiang Provincial Department of Science and Technology.The team said it came to the conclusion after evaluating technical documents and clinical test results Monday.This is the first time that transcranial magnetic stimulation has been adopted to treat Parkinson's disease, said Sun Zuodong, chairman of Aobo Medicine Apparatus Co., Ltd. (AMA), the developer based in the provincial capital Harbin.Transcranial magnetic stimulation is a noninvasive method which causes depolarization in the brains' neurons so as to restore the functions of brain nerves.The apparatus consists of three parts, namely brain wave stimulator, field effect cap and multiplier, said Sun.Clinical tests over more than 100 patients showed that the apparatus had a 70 percent success rate in reducing the disease's symptoms, according to Wang Aili, planning manager of AMA.The new equipment will help generation of dopamine, the reduction of which within the brain caused the disease, said Wang Weixiang, a consulting doctor with the Heilongjiang Provincial Rehabilitation Hospital.Parkinson's disease is a disorder of the neural system, which leads to limb tremors and difficulty in walking and other movements.China has 2 million patients suffering from Parkinson's disease, mostly people over the age of 50, and the number is increasing by 100,000 annually, said Dr. Wang.

BEIJING, May 25 (Xinhua) -- A researcher with the Chinese Academy of Agricultural Sciences (CAAS) said Wednesday that plant hormones, if used properly, are not a risk to human health."Irregular use of plant growth substances may cause plants to grow excessively fast or affect the taste, but will not cause harm to human health," Ye Zhihua said in an interview with Xinhua.His remarks come after media reports in China about "exploding watermelons," caused by the excessive use of phytohormone, have aroused public concern over the safety of hormones that stimulate plant growth.Ye said plant hormones used to promote growth have the same or similar effects as natural plant hormones, and fruit and vegetables sold at the market carried limited residue of the hormones.More than 100 types of plant hormones, such as ethephon and gibberellin acid, are used in agriculture and forestry sectors around the world, Ye said, adding 38 types of plant hormones have been registered in China.For example, seven plant hormones including thidiazuron and nucleotide are approved for use on cucumbers in China. The purpose is to stimulate the growth of female flowers and increase fruit yields, Ye said.Ye added that China places plant hormones in the category of pesticides control, which means the hormones are subject to strict management from production to utilization.

来源：资阳报